Do low levels of alanine aminotransferase, a baseline marker of sarcopenia and frailty, associate with worse clinical outcomes among hospitalized COVID-19 patients? A Retrospective Cohort Study

OBJECTIVES: COVID-19 geoperdize lives. Not all the risk factors for negative outcomes are known. Sarcopenia and frailty are common, negatively affecting clinical outcomes. Studies have shown that sarcopenia and frailty are associated with worse outcomes. Our objective was to examine whether low ALT...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatt, Ehud Raz, Zilber, Eyal, Perelman, Max, Landau, Nitsan, Yakir, Maya, Glick, Noam, Negru, Liat, Segal, Gad, Itelman, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HYLONOME PUBLICATIONS 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472039/
https://www.ncbi.nlm.nih.gov/pubmed/37663161
http://dx.doi.org/10.22540/JFSF-08-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472039/
https://www.ncbi.nlm.nih.gov/pubmed/37663161
http://dx.doi.org/10.22540/JFSF-08-148

Ejemplares similares